Back
Annovis Bio Vs. Akero Therapeutics Industry Stock Comparison
Sell
15
ANVS
Annovis Bio
Last Price:
8.45
Seasonality Move:
26.81%
Sell
44
AKRO
Akero Therapeutics
Last Price:
28.25
Seasonality Move:
-4.22%
Sell
15
Annovis Bio (ANVS)
is a Sell
Is Annovis Bio a Buy, Sell or Hold?
- The current Annovis Bio [ANVS] share price is $8.41. The Score for ANVS is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
- ANVS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
44
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $28.25. The Score for AKRO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ANVS Stock Price Chart
What is Annovis Bio's stock price today?
-
The Annovis Bio share price today is $8.41
The current trend is relatively stagnant and ANVS is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $28.25
The current trend is moderately bullish and AKRO is experiencing slight selling pressure.
ANVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 50.85 | Buy |
| Chaikin Money Flow: | 97327 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.99 - 8.49) | Buy |
| Bollinger Bands (100): | (6.47 - 10.45) | Sell |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.62 | Buy |
| Relative Strength Index (14 RSI): | 54.87 | Buy |
| Chaikin Money Flow: | -181922 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (26.24 - 28.48) | Buy |
| Bollinger Bands (100): | (21.77 - 27.59) | Buy |
ANVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.14 | Buy |
| 20-day SMA: | 8.25 | Buy |
| 50-day SMA: | 8.57 | Sell |
| 200-day SMA: | 9.65 | Sell |
| 8-day EMA: | 8.19 | Buy |
| 20-day EMA: | 8.27 | Buy |
| 50-day EMA: | 8.53 | Sell |
| 200-day EMA: | 9.33 | Sell |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 28.52 | Sell |
| 20-day SMA: | 27.59 | Buy |
| 50-day SMA: | 26.55 | Buy |
| 200-day SMA: | 23.9 | Buy |
| 8-day EMA: | 28.32 | Sell |
| 20-day EMA: | 27.79 | Buy |
| 50-day EMA: | 26.7 | Buy |
| 200-day EMA: | 25.86 | Buy |
Annovis Bio Earnings Growth & ANVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.73 per share, and a decrease next year of $0.56 per share.
Annovis Bio Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||